Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares UltraPro Short Dow30 ETF
SDOW
5
ProShares UltraPro Short QQQ ETF
SQQQ
CN Stock MarketDetailed Quotes
300233 Shandong Jincheng Pharmaceutical Group
- 16.03
- +0.02+0.12%
Market Closed Jun 16 15:00 CST
6.15BMarket Cap41.31P/E (TTM)
16.35High15.82Low117.42KlotVolume15.90Open16.01Pre Close189.05MTurnover3.16%Turnover Ratio31.25P/E (Static)383.87MShares23.0752wk High1.67P/B5.96BFloat Cap10.2552wk Low19.21Limit Up371.70MShs Float57.74Historical High12.81Limit Down3.31%Amplitude2.49Historical Low0.25Dividend TTM16.10Avg Price60.30KlotAsk1.56%Div Yield TTM100Lot Size53.69KlotBid
Shandong Jincheng Pharmaceutical Group News
China Securities Co.,Ltd.: In the second half of the year, the A-share market is expected to gradually shift upward in its volatile center, poised for potential growth. Focus on innovative drugs and other areas.
China Securities Co., Ltd. released a research report stating that in the second half of 2025, driven by the trend of a weak dollar, supportive policies in the Capital Markets, and an overall improvement in the liquidity environment, the A-share market's fluctuation center is expected to gradually rise, gathering momentum for a takeoff.
Shandong Jincheng Pharmaceutical Group: "The news about supplying ergothioneine to Proya Cosmetics and an Order exceeding 0.3 billion yuan is untrue."
On June 11, according to Gelonghui, an investor asked on an interactive platform whether the company supplied ergothioneine raw materials to international cosmetics brands such as Estee Lauder and Proya Cosmetics, with order amounts exceeding 0.3 billion yuan. Is this true? Shandong Jincheng Pharmaceutical Group responded that this information is not accurate, and if the company's operating information meets the disclosure standards, it will disclose the information in legal media according to the information disclosure rules.
Shandong Jincheng Pharmaceutical Group (300233.SZ): Fragrance and flavor products have already been awarded the fragrance and flavor procurement project of downstream traditional tobacco enterprises.
Gelonghui reported on June 11 that Shandong Jincheng Pharmaceutical Group (300233.SZ) stated on the interactive platform that the company has won bids for flavor and fragrance procurement projects from downstream traditional tobacco enterprises.
Is BD Trade a systematic exit opportunity? The expectations for investment in innovative drugs in the primary market are 'warming up'.
① Since the beginning of this year, the total amount of Trade for innovative drugs going overseas has reached 45.5 billion USD, with the down payment amounting to 2.2 billion USD. ② In terms of financing rounds, the proportion of early-stage innovative drugs has decreased. In the past, domestic projects in the mid-to-late stages that needed financial support often lacked backing from large PE funds. ③ With the boom in BD, the investment expectations for innovative drugs have changed. The market believes that BD is gradually becoming a systemic exit opportunity.
Jincheng Pharmaceutical's Units Get Nod to Market Antifungal, Anti-Infection Drugs
Shandong Jincheng Pharmaceutical Group (300233.SZ) subsidiary obtained two drug registration certificates.
Shandong Jincheng Pharmaceutical Group (300233.SZ) announced that its wholly-owned subsidiary Peking Jincheng Tail Pharmaceutical Co., Ltd. and the controlling subsidiary...
Express News | Shandong Jincheng Pharmaceutical Group: Subsidiary received the registration certificate for enteric-coated posaconazole tablets and injectable cefazolin sodium.
Shandong Jincheng Pharmaceutical Group (300233.SZ): In 2024, the company's overall revenue from exports to the United States will account for about 2%.
Gelonghui, on May 20, announced that Shandong Jincheng Pharmaceutical Group (300233.SZ) stated on the interactive platform that in 2024, the overall revenue from exports to the U.S. will account for about 2% of the company. The company will continue to pay attention to changes in tariff policies and maintain communication with customers!
Shandong Jincheng Pharmaceutical Group (300233.SZ): Ergothioneine has multiple physiological functions such as antioxidant, anti-inflammatory, and cell protection. The company has a small number of samples for sale.
On May 20, Gelonghui reported that Shandong Jincheng Pharmaceutical Group (300233.SZ) stated on the interactive platform that ergot alkaloids have various physiological functions such as antioxidant, anti-inflammatory, and cell protection, and can be used in food, pharmaceuticals, skincare, and other fields. The company has a small number of samples for sale, which has not yet had a significant impact on the company's performance.
Jincheng Pharmaceutical Signs Licensing, Distribution Deal With Theramex
Shandong Jincheng Pharmaceutical Group (300233.SZ) signed a license and distribution agreement for Estradiol Progesterone Soft Capsules.
Shandong Jincheng Pharmaceutical Group (300233.SZ) announced that the company recently entered into an agreement with Theramex HQ UK Li...
Express News | Shandong Jincheng Pharmaceutical Group: Signed a license and distribution agreement with Theramex.
Shandong Jincheng Pharmaceutical Group (300233.SZ): The equity distribution for the year 2024 is a dividend of 1.5 yuan per share, with the registration date on May 13.
On May 6, Gelonghui reported that Shandong Jincheng Pharmaceutical Group (300233.SZ) announced its annual equity distribution plan for 2024: based on the existing total share capital of the company, after excluding the repurchased shares of 4,543,000.00 shares, a total of 379,331,587.00 shares will be used as the basis for distributing cash of 1.500000 yuan per 10 shares (including tax) to all shareholders. The record date for this equity distribution is May 13, 2025. The ex-dividend date for this equity distribution is May 14, 2025.
Jincheng Pharmaceutical: Report for the first quarter of 2025
Express News | Shandong Jincheng Pharmaceutical Group: In the first quarter of 2025, the net income was 35.0548 million yuan, a year-on-year decrease of 57.75%.
Shandong Jincheng Pharmaceutical Group (300233.SZ): Jincheng Suzhi has been re-certified as a high-tech enterprise.
On April 21, Gelonghui reported that Shandong Jincheng Pharmaceutical Group (300233.SZ) announced that its wholly-owned subsidiary, Shanghai Jincheng Suzhi Pharmaceutical Co., Ltd. (referred to as "Jincheng Suzhi"), recently received the "High-tech Enterprise Certificate" issued jointly by the Shanghai Municipal Science and Technology Commission, the Shanghai Municipal Finance Bureau, and the Shanghai Municipal Taxation Bureau of the State Administration of Taxation. Issued date: December 26, 2024, Certificate number: GR202431002776, valid for three years.
Express News | Shandong Jincheng Pharmaceutical Group: Subsidiary pharmaceutical for injectable cefotaxime sodium has been approved.
Shandong Jincheng Pharmaceutical Group (300233.SZ): The revenue from the company's synthetic biology products such as glutathione and S-adenosylmethionine directly exported to the USA accounts for about 2%.
On April 8, Gelonghui reported that Shandong Jincheng Pharmaceutical Group (300233.SZ) stated on the investor interaction platform that the company's revenue from directly exporting synthetic biology products such as glutathione and SAM (S-adenosylmethionine) to the USA accounts for about 2%. According to the list of products exempt from Global tariffs and reciprocal tariffs released by the White House, and after preliminary communication with certain customers in the USA, the company's food-grade glutathione, SAM, and PQQ are included in the exemption list. The company will continue to monitor changes in tariff policies and maintain communication with customers.
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
Express News | Shandong Jincheng Pharmaceutical Group: The first phase of the employee stock ownership plan has been completed.
Market Insights
Tariff Storm Hits: Hedge with ETFs? Tariff Storm Hits: Hedge with ETFs?
The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals.
Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index.
This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content.
Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios. The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals.
Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index.
This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content.
Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios.
Unlock Now
Discussing
The Sino-US talks are back! How to seize investment opportunities recently?
On June 9 to 10 local time, the first meeting of the China-U.S. economic and trade consultation mechanism was held in London, United Kingdom
Food流油
Apr 14 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"
Investment Course
Essential Crypto strategies to learn for beginners.
Beginner's Guide: Understand how to invest in Crypto in 3 minutes.
Crypto (Cryptos) is, in simple terms, a virtual currency based on cryptographic principles to ensure transaction security. Unlike the currencies we use daily, C
How to Trade Crypto on Futubull
Step 1: Activate the Cryptos Account. Comprehensive Account > More > Account Management > Activate Trading Products > Select [Cryptos] to start the process. Not
A comprehensive review of crypto history
Have you heard the latest about Bitcoin? In 2024 H1, its value once surged by 68% . As the largest and most well-known cryptocurrency, Bitcoin has increased in